Address for submission of the exemption (all applications must be submitted in writing, via regular post):

Similar documents
Address for submission of the applications (all applications must be submitted in written form by regular post):

Title 17-A: MAINE CRIMINAL CODE

Final Report of the. (HB 151, Chapter 17:1, Laws of 2018) October 16, Membership. Rep. Peter W. Bixby, Clerk Rep. Howard Pearl.

Understanding the New Access to Cannabis for Medical Purposes Regulations

SUPER SNOUTS CBD150 & CBD300 OIL FOR DOGS & CATS

Supplement No. 1 published with Extraordinary Gazette No. 65 dated 19 th August, 2016.

Lobbyist-in-a-Box: (VPhAT) created on 01/15 at 10:11

MODIFICATION OF APPLICATION TO BECOME A LICENSED PRODUCER UNDER THE ACCESS TO CANNABIS FOR MEDICAL PURPOSES REGULATIONS

The Shifting Federal Regulation of Cannabis Products

CHAPTER 1 COMMUNITY PHARMACY M.ASHOKKUMAR DEPT OF PHARMACY PRACTICE SRM COLLEGE OF PHARMACY SRM UNIVERSITY

Pharmacokinetics and Administration Modes of Cannabinoids A Challenge

ADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP

I am pleased to highlight for this Honourable House and the public. that today the Government will be laying amendments to the

The Sale of Cannabis in Pharmacies. Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association

Cannabis Regulation in Canada:

IC ARTICLE 48. CONTROLLED SUBSTANCES

Unofficial translation /Ministry of Social Affairs and Health. No. 548/2008. Government Decree on Narcotics Control

DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT

Questions & answers on the use of cannabis sativa L. and cannabinoids (such as cannabidiol) as foodstuffs or within foodstuffs

Australian Medicinal Cannabis Pricing Analysis

Poisons Amendment (2018 Measures No. 1) Instrument 2018

from 21 June 2012 Mortality Overall mortality 1.6% vs. 0% Morbidity Absolute change in degree of spasticity (NRS score) [-1.29; -0.

CANNABIS MANAGEMENT CORPORATION REGULATIONS

SECTION PRESCRIPTIONS

Schedules of Controlled Substances: Placement in Schedule V of Certain FDA- Approved Drugs Containing Cannabidiol; Corresponding Change to Permit

Recent trends in medical cannabis use in Canada

HIV MANAGEMENT PROGRAMME APPLICATION FORM

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.

Oregon State University Guidance on Cannabis Research, Teaching, and Outreach Activities

(A) A practitioner or by the practitioner's authorized agent in the practitioner's presence; or

TEXAS COMPASSIONATE-USE ACT

Refilling a Prescription with No Refills Remaining

Vaccine Starter Kit Program FAQs

Swissmedic Approval Options and Limits. Swiss Task Force for Cannabinoids in Medicine Conference November 12, 2016

Initial Clinical History and Physical Form

SECTION V: EMPLOYEES POLICY 5375 MEDICAL MARIJUANA, HEMP & CANNABIDIOL (CBD)

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices

Medicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system

PLEASE NOTE. For more information concerning the history of this Act, please see the Table of Public Acts.

Practice Direction Refill History Recording System

Senate File Introduced

CDPHE Position Regarding Hemp Extracts as an Adulterated Substance in Foods

The Cannabis Legal Landscape Today. Erika Lietzan University of Missouri School of Law November 2018

2016 Travelers Prescription Drug Plan Blue Cross Blue Shield Plan and United Healthcare Choice Plus Plan

Ultimate Guide: Everything You Need To Know Before Buying CBD Hemp Oil

THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL AN ACT

PART 1306 PRESCRIPTIONS. 21 CFR Ch. II ( Edition)

Medical Cannabis MATT WEBSTER DO, MS

ORDER OF THE LIEUTENANT GOVERNOR IN COUNCIL

ANALYTICAL CHEMISTRY OF CANNABINOIDS IN PLANT MATERIAL AND BODY FLUIDS, AN UNRENOUNCEABLE TOOL FOR LAW ENFORCEMENT, PROSECUTION AND JUDGEMENT

The Determination of CBD and General Cannabinoid Content in Hemp Oils Using HPLC with UV Detection

Are We All Going to Pot?: Legal Issues Arising from Cannabis-Industry Growth The Canadian Perspective

Endocannabinoid System Cannabinoid Drugs

Establishment of a New Drug Code for Marihuana Extract. AGENCY: Drug Enforcement Administration, Department of Justice.

THE COMPLETE CBD GUIDE

Medical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility.

AN ACT. relating to the medical use of low-thc cannabis and the regulation. of related organizations and individuals; requiring a dispensing

Research: Medical Cannabis

Have approved and decreed: Chapter 1 Definitions

Cannabis derived terpenes for sale

O vercom ing Banking Obstacles for Marijuana-Related Businesses. Lori Jean Partner, Krieg DeVault LLP

Overview of Cannabis Laws

2018 OAAS CONVENTION. Fair s and Marijuana. Shawn LaPalm

MEMORANDUM. DATE: November 19, Senator Kohl-Welles. Kathleen Buchli, Counsel medical marijuana proposal

Daniel Fabricant, Ph.D

SENATE BILL No. 676 AMENDED IN SENATE APRIL 28, 2011 AMENDED IN SENATE MARCH 31, Introduced by Senator Leno.

Dispensing and administration of emergency opioid antagonist without a

The products being taken by children with epilepsy are not the equivalent of the marijuana widely used for recreational purposes.

CARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date:

Begun and held at the City of Washington on Friday, the twentieth day of April, two thousand and eighteen. JOINT RESOLUTION

2018 Farm Bill to Lift Federal Prohibition on Hemp Production, but State Laws May Restrict Certain Activities

Humboldt Distillery (Non-Council member)

The public comment period for form and method of administration rules is now closed. There will be additional opportunities to provide public comment

Guideline for the Rational Use of Controlled Drugs

INFORMATION FOR FILLING OUT APPLICATION FORM FOR AN EXEMPTION TO USE A CONTROLLED SUBSTANCE FOR SCIENTIFIC PURPOSES (a Health Canada document)

CITY OF BUCKLEY, WASHINGTON ORDINANCE NO

Medical Marijuana. Navigating Medical Marijuana in Workers Compensation

Explanatory Notes Relating to Regulatory and Legislative Proposals Relating to the Taxation of Cannabis

PATIENT INTAKE FORM. Name: Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell:

Marijuana: Laws Allowing the Limited Use of Low-THC Oil for Medicinal Purposes

Proposed Excise Duty Framework for Cannabis Products

Electronic Prescription Service in England. Ian Lowry Programme Manager

Industrial Hemp In Colorado

FAQ. A. No, Nature s Ultra products are formulated with a CBD isolate, which by definition contains no THC.

Strategies to Prevent Pharmaceutical Waste: Modifying Co-Pay Structures

CBD OIL BUYER S GUIDE

CHAPTER Committee Substitute for Committee Substitute for Senate Bill No. 1030

Specification Sheet : Hemp CBD Isolate

Industrial Hemp Registration Application Complete registrations are due by May 1 st, annually

FOOD-BASED FUNDRAISING ESSENTIAL INFORMATION

Marijuana Law. Selected Legal Issues. Brian N. Morrow, Esq.

ORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies

Medical Cannabis and OMT

April 7, You have asked me to prepare an opinion letter regarding the legal status of cannabidiol ( CBD ).

79th OREGON LEGISLATIVE ASSEMBLY Regular Session. Senate Bill 1015 SUMMARY

3.5 Strengthen the prevention and treatment of substance abuse, including narcotic drugs and harmful use of alcohol 3.3 Ending the AIDS epidemic and

Rental Addendum Prohibiting Smoking

Much Ado About Nothing: Cannabis and the Current Administration

Sub. S.B. 119 As Passed by the Senate

This questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level.

Transcription:

Checklist for applications for an exemption to prescribe Dronabinol solution 2.5% OR Cannabis tincture normalized (10 mg THC/ml) OR Cannabis oil normalized (10 mg THC/ml) For granting a special permit for Marinol or Dronabinol solution (or cannabis tincture or cannabis oil) to patients in accordance with article 8, paragraph 5 of the Federal Law on Narcotic Drugs of October 3, 1951 (BetmG), an application with the following informations and documents needs to be submitted to the Federal Health Office (see address below). Name, first name, date of birth and address of the patient Indication Indication of the drugs used to date for the treatment of this specific disease Intended delivery form (dronabinol solution, cannabis tincture or cannabis oil) and intended dosage Provisional treatment duration Written consent of the patient for treatment with dronabinol / cannabis tincture / cannabis oil Written confirmation from the responsible physician to take full responsibility for all consequences of his prescription of dronabinol, cannabis tincture or cannabis oil written approval from the responsible physician to prepare an interim report on the progress of the treatment every 6 months, as well as to draw up a final report and to send these reports to the Federal Office of Public Health A detailed description of the type of patient monitoring and care (at the start and after stabilization) Intended supplier: Bahnhofapotheke Langnau AG, Dorfstr. 2, 3550 Langnau Provisional flow of logistics for delivering the drug to the patient (direct delivery to the patient, direct delivery by the responsible physician or delivery by a public pharmacy or hospital pharmacy) If the medication is to be delivered from a public pharmacy / hospital pharmacy: indicate the name and address of the pharmacy Information on the nature of the financing of the therapy, since the costs do not necessarily have to be covered by the health insurance fund Address for submission of the exemption (all applications must be submitted in writing, via regular post): Eidgenössisches Departement des Innern EDI Bundesamt für Gesundheit BAG Nationale Präventionsprogramme NPP Schwarzenburgstrasse 157 3003 Bern Tel. +41 58 463 87 90

Information for the delivery of dronabinol solution 2.5% OR Cannabis tincture (10 mg THC/ml) OR Cannabis oil (10 mg THC/ml) Application / request Eidgenössisches Departement des Innern EDI Bundesamt für Gesundheit BAG Nationale Präventionsprogramme NPP Schwarzenburgstrasse 157 3003 Bern Delivery The prescribed Dronabinol solution (or Cannabis tincture or Cannabis oil) is "registered mail" and will be delivered at the a) address of the physician or b) delivered to a pharmacy or c) directly to the patient (with the statement "personal signature") Billing Two options: a) amount paid by patient or health insurance Normal selling price b) amount paid by physician or pharmacy Normal selling price minus 10% discount Dronabinol solution (or Cannabis tincture or Cannabis oil) is not a standard benefit of health insurance. Please clarify in advance with the health insurance (provide cover), whether the drug will be taken on charge or not. Delivery time The dronabinol solution, Cannabis tincture or Cannabis oil will be delivered within 1-3 days once we are in possession of: Copy of the decision of the BAG (E.g. by fax) Narcotic prescription (original version), including quantity and dosage instructions If a longer duration of the treatment is to be foreseen, and the amount needed is difficult to be estimated, the narcotic drug prescription can be determined for a certain period of time (E.g. valid for 2 months, but for maximum 3 months). Otherwise, for each new order it takes a new narcotic prescription (same handling like other drugs, which are under narcotic law) For questions: 3550 Langnau (press button 2 after the recorded message) Fax 034 402 25 35 Mail:

Dronabinol solution 2,5 % (NRF 22.8.) Dronabinol is the international non-proprietary name for Delta-9-tetrahydrocannabinol (THC) Dropper bottle 5g (equivalent to 125 mg Dronabinol) Fr. 220.00 1 mg Dronabinol costs Fr. 1.76 10g (equivalent to 250 mg Dronabinol) Fr. 425.00 1 mg Dronabinol costs Fr. 1.70 20g (equivalent to 500 mg Dronabinol) Fr. 825.00 1 mg Dronabinol costs Fr. 1.65 40g (equivalent to 1000 mg Dronabinol) Fr. 1600.00 1 mg Dronabinol costs Fr. 1.60 Daily treatment costs (based on 10 g bottle) Daily intake of 5mg Fr. 8.50 Daily intake of 10 mg Fr. 17.00 Daily intake of 20 mg Fr. 34.00 36 drops correspond an average of 1.0 g solution. 360 drops correspond an average of 10.0 g solution. Conversion Table (mg drops accordingly) Note: special, standardized droplet 1 drop corresponds to 0.7 mg THC 3-4 drops correspond to 2,5 mg THC 7 drops correspond to 5,0 mg THC 10 drops correspond to 7,0 mg THC 15 drops correspond to 10,0 mg THC 20 drops correspond to 14,0 mg THC 36 drops (= 1 g of sol.) corresp. to 25,0 mg THC (Density of dronabinol solution 2.5%: about 0.95 g / cm3) Practical example: 3 x daily 2.5 mg Dronabinol (=3 x daily 3-4 drops) 3 x daily 5.0 mg Dronabinol (=3 x daily 7 drops) 3 x daily 10.0 mg Dronabinol (=3 x daily 15 drops) Dosage and administration The dosage is individual and determined by the physician. Depending on the indication, the daily dose can vary from 2.5 mg to 30 mg Dronabinol. In exceptional cases, the dosage might even be higher. The oily droplets are preferably taken with fatty food (for example, drop on a cookie or drop in some dressing oil). When counting the drops position the bottle in a vertical axis (even). Durability/Stability From the date of manufacture, the medicine is stable for 6 months. The solution is conserved with the natural preservative ascorbyl palmitate (0.05%). In rare cases a slight reddening of the solution may occur, which has no effect on effectiveness and durability. The solution should be stored at room temperature.

Cannabis tincture normalized (about 10 mg THC / ml Cannabis sativa extractum fluidum normatum Charge Nr. 1634 1901 Cannabis tincture normalized "standardized", on Stand: Januar 2017 11 mg THC total/g 22 mg CBD total/g Veral bottle, brown (with separate pipette) 10 ml (= 9.1 g) corresponds to approx. 100 mg THC CHF 120.00 1 mg THC costs CHF 1.20 20 ml (= 18.2 g) corresponds to approx. 200 mg THC CHF 230.00 1 mg THC costs CHF 1.15 50 ml (= 45.5 g) corresponds to approx. 500 mg THC CHF 550.00 1 mg THC costs CHF 1.10 (Density of ethanolic tincture (ethanol content: 80% V / V): 0.8784 g / cm3 at 20 C) Day-therapy costs (based on 20 ml bottle) Daily dose 5 mg CHF 5.75 Daily dose 10 mg CHF 11.50 Conversion table (drop corresponding to mg), dropper pipette, Art. 14.014.00 1 drop of tincture corresponds to 0.29 mg THC 3-4 drops of tincture correspond to 0.87 mg ( ca. 1 mg) THC ( ca. 2 mg) CBD 9 drops of tincture correspond to 2.61 mg ( ca. 2.5mg) THC ( ca. 5 mg) CBD 10 drops of tincture correspond to 2.9 mg THC 17 drops of tincture correspond to 4.93 mg ( ca. 5 mg) THC ( ca. 10 mg) CBD 34 drops of tincture correspond to 9.86 mg ( ca. 10 mg) THC ( ca. 20 mg) CBD 350 drops (10 ml) of tinct. correspond to 101.5 mg THC The number of drops per bottle can vary slightly (depending on the inclination of the pipette and temperature) 1 drop of the tincture has the weight of 0.0260 g, which means that this contains 0.29 mg THC Dosage The dosage is individual and is determined by the physician. Depending on the indication, the daily dose may range from 2.5 mg to 30 mg THC. Standard dosage: 2 to 3 x daily 2.5 mg (corresponds to 2 to 3 x daily 8-9 drops). The drops are taken with little water. Durability Expiry date: is indicated on the dispensing bottle. Alcohol: 74.0% (m / m) > 80% (v / v). The cannabis tincture should be stored in the refrigerator (2-8 C) in order to prevent loss of efficacy. The tincture must be protected from light (in a brown medicinal bottle) and must be well closed after use.

Cannabis oil normalized (about 10 mg THC / ml) Cannabis sativa extractum oleatum Charge Nr. 1645 3901 Cannabis oil normalized "standardized", on Stand: Januar 2017 11.0 mg THC total/g 24.0 mg CBD total/g Aponorm bottle, brown (with separate pipette) 10 ml (= 9.23 g) corresponds to approx. 110.7 mg THC CHF 165.00 1 mg THC costs CHF 1.50 20 ml (= 18.36 g) corresponds to approx. 220.4 mg THC CHF 320.00 1 mg THC costs CHF 1.45 50 ml (= 46.15 g) corresponds to approx. 553.8 mg THC CHF 775.00 1 mg THC costs CHF 1.40 (Density of the oily solution: 0.9291 g / cm 3 at 20 C) Day-therapy costs (based on 20 ml bottle) Daily dose 5 mg CHF 7.25 Daily dose 10 mg CHF 14.50 Conversion table (drop corresponding to mg), dropper pipette, Art. 14.014.00 1 drop of oil ca. 0.033 g corresponds to 0.40 mg THC 0.86 mg CBD 3 drops of oil 0.1 g correspond to 1.2 mg THC 2.6 mg CBD 6 drops of oil 0.2 g correspond to 2.5 mg THC 5.2 mg CBD 12-13 drops of oil 0.4 g correspond to 5.0 mg THC 11.0 mg CBD 25 drops of oil 0.8 g correspond to 10.0 mg THC 21.5 mg CBD 30 drops of oil 1.0 g correspond to 12.0 mg THC 26.0 mg CBD 277 drops (10 ml) of oil 9.23 g correspond to 111 mg THC 238 mg CBD The number of drops per bottle can vary slightly (depending on the inclination of the pipette and temperature) Dosage The dosage is individual and determined by the physician. Depending on the indication, the daily dose can vary from 2.5 mg to 30 mg Dronabinol. In exceptional cases, the dosage might even be higher. The oily droplets are preferably taken with fatty food (for example, drop on a cookie or drop in some dressing oil). When counting the drops, position the bottle in a vertical axis (even). Durability Expiry date: Is indicated on the dispensing bottle. As a carrier oil, a biological hemp seed oil is used which is stabilized with the natural preservative ascorbyl palmitate (0.05%). The solution is stable for 6 months. It is recommended to keep the oil in the refrigerator.